However, one statement has indicated no correlation between the use of corticosteroids and hypertension [7]

However, one statement has indicated no correlation between the use of corticosteroids and hypertension [7]. statement the case of a patient with SLE and malignant hypertension with hypertensive retinopathy that initially presented without medical evidence of APS or hypertensive nephropathy. Keywords:Lupus erythematosus, systemic; Hypertension, malignant == Intro == Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that is characterized by a wide spectrum of medical manifestations, including renal, pulmonary, cardiovascular, and neuropsychiatric abnormalities [1]. In particular, cardiovascular manifestations such as Olmesartan medoxomil myocarditis, valvular heart disease, pericardial effusion, coronary heart disease, and systemic hypertension have been widely recognized in individuals with SLE. Keith et al. [2] initially explained malignant hypertension as a disease entity. Prior to the development of effective anti-hypertensive medicines, malignant hypertension lead to death within about one year after diagnosis. However, Rabbit Polyclonal to VAV1 (phospho-Tyr174) the incidence and mortality of malignant hypertension offers declined since the development of new restorative strategies, including artificial renal alternative therapy and novel medications that are capable of effectively controlling hypertension-related mechanisms or pathways [3]. Malignant hypertension may develop with either essential or secondary hypertension resulting from the fundamental or as a disease complication. The main causes of secondary malignant hypertension are thought to be parenchymal renal or renovascular lesions irrespective of the fundamental disease [3]. Malignant hypertension has been reported in association with autoimmune rheumatic diseases and in individuals with the antiphospholipid antibody syndrome (APS) only or with SLE and is relatively well explained in the medical literature [4]. However, malignant hypertension as the initial demonstration of SLE, only without APS, has not been previously reported. Here, we statement a case of lupus nephritis showing with malignant hypertension, without clinically obvious APS, and hypertensive nephrosclerosis on renal biopsy. == CASE Statement == A 38-year-old female was referred for the evaluation of visual disturbance and headache enduring for over 3 weeks. Two weeks prior to her visit to our clinic, the patient complained of myalgia, cough and non-productive sputum without clearly identifiable causes. In addition, the visual disturbance and headache were Olmesartan medoxomil worsening. The patient visited the division of ophthalmology for the visual disturbance, and was diagnosed with hypertensive retinopathy. Anithypertensive medications were prescribed. The physical exam at the initial check out revealed high Olmesartan medoxomil blood pressure, 190/110 mmHg, a respiration rate of 25/min and a heart rate of 113 beats/min. The breath sounds in the remaining lung field were decreased and moderate pitting edema of both lower extremities was mentioned. The laboratory studies included a complete blood count number and acute phase reactants, the results showed: white blood count number 3,700/mm3, hemoglobin 9.4 g/dL, platelets 12,700/dL, erythrocyte sediment rate 50 mm/hr (normal < 20 mm/hr), and C-reactive protein 8.5 mg/dL (normal < 0.5 mg/dL). Program chemistry exposed some abnormal results, including a total protein 6.9 g/dL, albumin 2.8 g/dL, creatinine 1.6 mg/dL (normal < 1.5 mg/dL), and cholesterol 202 mg/dL. Immunological testing for autoimmune diseases showed an antinuclear antibody (ANA) titer of 1 1:320 having a speckled pattern, and 56.10 IU/mL of antibody to anti-double-stranded DNA (normal < 5 IU/mL). The complement levels were decreased to 37.9 mg/dL for C3 and 4.3 mg/dL for C4. Checks for the lupus anticoagulant, anti-cardiolipin antibody of IgM, IgG and IgA, anti 2-glycoprotein1 (2-GP1), and venereal disease study laboratory test (VDRL) were all negative. The initial urinalysis showed albumin 2+, reddish blood cell count number > 30/HPF and WBC 1 to 3/HPF in a spot urine. Significant proteinuria of 6,489 mg was determined in the 24-hour urine. Simple chest radiography showed cardiomegaly having a moderate remaining pleural effusion. Renal arterial stenosis was not detected within the computed tomography angiography of the belly. The findings of the transthoracic echocardiography exposed a small to moderate pericardial effusion, large remaining pleural effusion with fibrinous material, enlargement of the remaining atrium, and remaining ventricular concentric hypertrophy. Within the fundoscopic exam, serious retinal detachment, cotton-wool places and retinal hemorrhages, of both eyes were, compatible with a hypertensive retinopathy grade III (Fig. 1A). Magnetic resonance imaging with angiography of the brain showed no certain abnormal findings. == Physique 1. == (A) Retinal detachments, multiple cotton-wool places and retinal hemorrhages mentioned before treatment. (B) After treatment, retinal hemorrhages, cotton-wool places and detachments were nearly resolved. The patient was diagnosed with SLE based on the medical features and laboratory results including the ANA, pleural and pericardial serositis, anti-dsDNA, and renal involvement with massive proteinuria; the findings fulfilled the American College of Rheumatology classification criteria Olmesartan medoxomil for the analysis of SLE [5]. The patient also met the entire world Health Corporation (WHO) criteria for malignant hypertension. The renal biopsy exposed a membranous lupus nephritis according to the WHO histopathology criteria; there was no evidence of hypertensive.